Synthesis and properties of radiolabeled CPTA-oligonucleotides

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 46, Issue 2, 2003, Pages 175-186

  Wagner, S ^a   Eritja, R ^b   Zuhayra, M ^a   Oberdorfer, F ^a   Mohammed, A ^c   Mier, W ^c   Haberkorn, U ^c   Eisenhut, M ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

99mTc; CPTA; Oligonucleotides; Solid phase synthesis

Indexed keywords

BENZOIC ACID; CHLORINE COMPOUNDS; SYNTHESIS (CHEMICAL);

99MTC; ANTISENSE OLIGODEOXYNUCLEOTIDES; CPTA; DNA SYNTHESISS; METHYL BENZOIC ACID; OLIGODEOXYNUCLEOTIDES; PROPERTY; SOLID PHASE SYNTHESIS; SOLID PHASIS; SOLID-PHASE;

OLIGONUCLEOTIDES;

1,3 PROPANEDIOL; 4 [(1,4,8,11 TETRAAZACYCLOTETRADEC 1 YL) METHYL]BENZOIC ACID; ANTISENSE OLIGONUCLEOTIDE; BENZOIC ACID DERIVATIVE; EXONUCLEASE; STANNOUS CHLORIDE; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL MODIFICATION; COMPLEX FORMATION; DNA SYNTHESIS; DRUG CONJUGATION; DRUG STABILITY; DRUG SYNTHESIS; ENZYME DEGRADATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; MASS SPECTROMETRY; POSITRON EMISSION TOMOGRAPHY; RADIOCHEMISTRY; REACTION ANALYSIS; REDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0037331001     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlcr.656     Document Type: Article

References (24)

1. Mirabelli CK, Crooke ST. Antisense oligonucleotides in the context of modern molecular drug discovery and development. In Antisense Research and Applications, Crooke ST, Lebleu B (eds). CRC Press: Boca Raton, FL, 1993; 7-35.
2. Gura T. Science 1995; 270: 575-577.
3. Matteucci MD, Wagner RW. Nature 1996; 384: 20-22.
4. Hildebrandt M, Reske SN. Nuklearmedizin 1996; 35: 126-131.
5. Sasmor HM, Dellinger DJ, Zenk PC, Lee LP. J Label Compd Radiopharm 1994; 36: 15-31.
6. Dewanjee MK, Ghafouripour AK, Kapakvanjwala M, et al. J Nucl Med 1994; 35: 1054-1063.
7. Childs RL, Hnatowich DJ. J Nucl Med 1985; 26: 293-299.
8. Hnatowich DJ, Winnard P Jr., Virzi F, J Nucl Med 1995; 36: 2306-2314.
9. Zhang YM, Liu N, Zhu ZH, Rusckowski M, Hnatowich DJ. Eur J Nucl Med 2000; 27: 1700-1707.
10. Tavitian B, Terrazzino S, Kuhnast B, et al. Nat Med 1998; 4: 467-471.
11. Kühnast B, Dollé F, Vaufrey F, Hinnen F, Crouzel C, Tavitian B. J Label Compd Radiopharm 2000; 43: 837-848.
12. Kühnast B, Dollé F, Terrazzino S, et al. Bioconjug Chem 2000; 11: 627-636.
13. Wu F, Yngve U, Hedberg E, et al. Eur J Pharm Sci 2000; 10: 179-186.
14. Kobori N, Imahori Y, Mineura K, et al. Neuroreport 1999; 10: 2971-2974.
15. Franz J, Freeman GM, Barefield EK, et al. Nucl Med Biol 1987; 14: 479-484.
16. Zuckman SA, Freeman M, Troutner DE, et al. Inorg Chem 1981; 20: 2386-2389.
17. Riche F, Vidal M, Mathieu JP, Pasqualini R, Fagret D, Comet M. Appl Radiat Isot 1996; 47: 51-56.
18. Troutner DE, Simon J, Ketring AR, Volkert W, Holmes RA. J Nucl Med 1980; 21: 443-448.
19. Seela F, Kaiser K. Nucl Acids Res 1987; 15: 3113-3129.
20. Motekaitis RJ, Rogers BE, Reichert DE, Martell AE, Welch MJ. Inorg Chem 1996; 35: 3821-3827.
21. Abrams MJ, Juweid M, tenKate CI, et al. J Nucl Med 1990; 31: 2022-2028.
22. Egli A, Alberto R, Tannahill L, et al. J Nucl Med 1999; 40: 1913-1917.
23. Brown T, Brown D. Modern machine-aided methods of oligodeoxyribonucleotide synthesis. In Oligonucleotides and Analogues - A Practical Approach, Eckstein F (ed). Oxford University Press: Oxford, 1991; 2-24.
24. Wagner S, Eisenhut M, Eritja R, Oberdorfer F. Nucleos Nucleot 1997; 16: 1789-1792.